Trial Profile
A study to evaluate risk of cardiovascular disease events with atazanavir-based antiretroviral treatment regimens in HIV-infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2017
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 02 Jan 2017 New trial record